Ghazarian Armen A, Trabert Britton, Graubard Barry I, Schwartz Stephen M, Altekruse Sean F, McGlynn Katherine A
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Epidemiology Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cancer. 2015 Dec 1;121(23):4181-9. doi: 10.1002/cncr.29643. Epub 2015 Aug 17.
The incidence of testicular germ cell tumors (TGCTs) in the United States is notably higher among white men versus other men. Previously, however, it was reported that rates were rising among Hispanics in certain areas. To determine whether this finding was evident in a wider area of the United States, data from 39 US cancer registries were examined.
Racial/ethnic-specific incidence rates per 100,000 man-years were calculated overall and by census region for the period of 1998-2011. Annual percentage changes (APCs) were estimated, and joinpoint models were fit. Differences in incidence by region were examined with the Wald test.
From 1998 to 2011, 88,993 TGCTs were recorded. The TGCT incidence was highest among non-Hispanic whites (6.57 per 100,000), who were followed by Hispanics (3.88), American Indians/Alaska Natives (2.88), Asians/Pacific Islanders (A/PIs; 1.60), and non-Hispanic blacks (1.20). The incidence significantly increased among Hispanics (APC, 2.31; P < .0001), with rates rising in all regions except the South. Rates rose slightly among non-Hispanic whites (APC, 0.51; P = .0076). Significant differences in rates by region were seen for Hispanics (P = .0001), non-Hispanic whites (P < .0001), and A/PIs (P < .0001), with the highest rates among Hispanics in the West and with the highest rates among non-Hispanic whites and A/PIs in the Northeast.
Although the incidence of TGCTs remained highest among non-Hispanic whites between 1998 and 2011, the greatest increase was experienced by Hispanics. Rising rates of TGCTs among Hispanics in the United States suggest that future attention is warranted. Reasons for the increase may include variability in birthplace, changing exposures, genetic susceptibility, and the length of US residence.
在美国,白人男性睾丸生殖细胞肿瘤(TGCT)的发病率明显高于其他男性。然而,此前有报道称,在某些地区西班牙裔的发病率正在上升。为了确定这一发现在美国更广泛地区是否明显,我们检查了来自39个美国癌症登记处的数据。
计算了1998 - 2011年期间每10万人年的种族/族裔特异性发病率,并按普查区域进行了计算。估计了年度百分比变化(APC),并拟合了连接点模型。通过Wald检验检查了各区域发病率的差异。
1998年至2011年期间,共记录了88993例TGCT。TGCT发病率在非西班牙裔白人中最高(每10万人中6.57例),其次是西班牙裔(3.88例)、美国印第安人/阿拉斯加原住民(2.88例)、亚裔/太平洋岛民(A/PI;1.60例)和非西班牙裔黑人(1.20例)。西班牙裔的发病率显著上升(APC,2.31;P <.0001),除南部地区外,所有地区的发病率都在上升。非西班牙裔白人的发病率略有上升(APC,0.51;P =.0076)。西班牙裔(P =.0001)、非西班牙裔白人(P <.0001)和A/PI(P <.0001)在各区域的发病率存在显著差异,西班牙裔在西部的发病率最高,非西班牙裔白人和A/PI在东北部的发病率最高。
尽管1998年至2011年期间TGCT的发病率在非西班牙裔白人中仍然最高,但西班牙裔的发病率增长最大。美国西班牙裔TGCT发病率的上升表明未来需要予以关注。发病率上升的原因可能包括出生地的差异、接触因素的变化、遗传易感性以及在美国居住的时间。